Search papers, labs, and topics across Lattice.
This review explores the integration of manganese-based materials with gelatin methacryloyl (GelMA) hydrogels to create multifunctional platforms for precision oncology, highlighting their roles in tumor diagnosis, localized therapy, and real-time monitoring via MRI. Manganese ions enhance T1-weighted MRI contrast and can modulate the tumor microenvironment, promoting immunogenic cell death and activating immune pathways. The paper discusses the construction of these manganese-functionalized GelMA systems, their therapeutic potential, and the challenges related to toxicity and clinical translation.
Manganese-functionalized GelMA hydrogels could revolutionize precision oncology by enabling real-time MRI-guided immunotherapy with enhanced therapeutic efficacy.
Precision oncology requires multifunctional platforms capable of integrating accurate tumor diagnosis, localized therapeutic delivery, immune modulation, and real-time monitoring of treatment response. Gelatin methacryloyl (GelMA) hydrogels have emerged as versatile biomaterials for biomedical engineering because of their biocompatibility, extracellular matrix-like structure, tunable mechanical properties, photocrosslinkability, and capacity to incorporate therapeutic agents, imaging probes, and functional nanomaterials. In parallel, manganese-based materials have gained increasing attention as promising alternatives to gadolinium-based magnetic resonance imaging contrast agents and as therapeutic components capable of modulating the tumor microenvironment. Manganese ions and manganese-based nanomaterials can enhance T1-weighted MRI contrast, generate reactive oxygen species, relieve tumor hypoxia, deplete glutathione, promote immunogenic cell death, and activate the cyclic GMP-AMP synthase-Stimulator of Interferon Genes pathway. The integration of manganese-based systems with GelMA hydrogels offers a promising strategy for developing localized, stimuli-responsive, and MRI-guided immunotheranostic platforms. This review summarizes the fundamental properties of GelMA hydrogels, the diagnostic and therapeutic roles of manganese-based materials, strategies for constructing manganese-functionalized GelMA systems, and their potential applications in precision oncology. Current challenges, including manganese-associated toxicity, controlled ion release, mechanical optimization, reproducibility, and clinical translation, are also discussed. Finally, future directions are proposed for the rational design of safe, scalable, and personalized manganese-functionalized GelMA platforms for cancer diagnosis and therapy.
